| 0% | Platelet count above 50,000 and asymptomatic; or for immune thrombocytopenia in remission | Your platelet count is above 50,000 and you have no symptoms, or your ITP is in remission. DC 7705 prints this 0 percent row itself, so it is a rung of the code rather than one § 4.31 has to supply. A 0 percent pays nothing, but it establishes service connection and fixes the effective date any later increase runs from. The lowest compensable rung on this code is 10 percent, and reaching it takes a platelet count that has fallen to 50,000 or below — a count above 50,000 does not reach it however long it has been low. |
|---|
What supports this level- Serial platelet counts recorded above 50,000
- Treatment notes recording no bleeding, bruising or other symptoms
- A hematology note stating the immune thrombocytopenia is in remission
- A dated record of the diagnosis so that a later increase claim has a starting point
|
| 10% | Platelet count higher than 30,000 but not higher than 50,000, not requiring treatment | Your platelet count has fallen into the band higher than 30,000 but not higher than 50,000, and it requires no treatment. |
|---|
What supports this level- Serial platelet counts in the band higher than 30,000 but not higher than 50,000
- Treatment notes showing the count is being observed rather than treated
- Pharmacy records showing no oral corticosteroid prescribed for the ITP
- Records showing no intravenous immune globulin has been given
|
| 30% | Platelet count higher than 30,000 but not higher than 50,000, with either immune thrombocytopenia or mild mucous membrane bleeding which requires oral corticosteroid therapy or intravenous immune globulin | Your platelet count is in the same band — higher than 30,000 but not higher than 50,000 — and now it is being treated: either the immune thrombocytopenia itself or mild bleeding from the mucous membranes (gums, nose) requires oral corticosteroid therapy or intravenous immune globulin. |
|---|
What supports this level- Serial platelet counts in the band higher than 30,000 but not higher than 50,000
- Pharmacy records for oral corticosteroid therapy (for example prednisone) given for the ITP
- Infusion records for intravenous immune globulin
- Treatment notes documenting mild mucous membrane bleeding such as bleeding gums or nosebleeds
|
| 70% | Requiring immunosuppressive therapy; or for a platelet count higher than 30,000 but not higher than 50,000, with history of hospitalization because of severe bleeding requiring intravenous immune globulin, high-dose parenteral corticosteroids, and platelet transfusions | You require immunosuppressive therapy — that prong carries 70 percent on its own, whatever your platelet count is. The alternative route is a count in the band higher than 30,000 but not higher than 50,000 together with a history of hospitalization for severe bleeding that took intravenous immune globulin, high-dose corticosteroids given by injection or infusion, and platelet transfusions. |
|---|
What supports this level- Records of immunosuppressive therapy prescribed for the ITP
- Hospital admission records for severe bleeding
- That admission recording intravenous immune globulin, high-dose parenteral corticosteroids and platelet transfusions together
- Serial platelet counts in the band higher than 30,000 but not higher than 50,000, for the hospitalization route
|
| 100% | Requiring chemotherapy for chronic refractory thrombocytopenia; or a platelet count 30,000 or below despite treatment. Note (2): A 100 percent evaluation shall continue beyond the cessation of chemotherapy. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter | You require chemotherapy for chronic refractory thrombocytopenia, or your platelet count is 30,000 or below despite treatment. Note (2) to DC 7705 provides that this 100 percent continues beyond the end of chemotherapy, with a mandatory VA examination six months after treatment stops; any reduction that follows is subject to 38 CFR 3.105(e). |
|---|
What supports this level- Chemotherapy administration records naming chronic refractory thrombocytopenia as the indication
- Serial platelet counts recorded at 30,000 or below
- Treatment records showing those counts persisted while treatment was being given
- The date chemotherapy stopped, which is what the six-month mandatory examination runs from
|